Gempharmatech Co. Ltd. A

Price Chart

Risk-Adjusted Performance

Gempharmatech Co. Ltd. A (688046) Price Performance

Gempharmatech Co. Ltd. A (688046) trades on SHG in CNY. The company is classified in the Healthcare sector under the Biotechnology industry. The stock currently trades at CNY19.55, up 0.05% from the previous close.

Over the past year, 688046 has traded between a low of CNY11.27 and a high of CNY19.72. The stock has gained 73.5% over this period. It is currently 73.5% above its 52-week low.

Gempharmatech Co. Ltd. A has a market capitalization of $8.27B, with a price-to-earnings ratio of 50.40.

About Gempharmatech Co. Ltd. A

GemPharmatech Co., Ltd., a contract research organization, provides genetically engineered mouse models and preclinical research services to the scientific community worldwide. The company offers mouse models, including knockout and conditional knockout mouse, disease mouse, immunodeficient mouse, germ-free mouse, and tool mice models, as well as operates wild mouse project. It also provides custom model generation, preclinical testing, germ-free and microbiome, cell lines and customization, custom breeding, animal quality testing, and other services. The company has a strategic alliance with Memorial Sloan Kettering Cancer Center (MSK) to accelerate the discovery of new therapeutic antibodies. The company was founded in 2017 and is headquartered in Nanjing, China.

Compare Gempharmatech Co. Ltd. A

Side-by-side comparison against top Healthcare peers.